In the 1950s and 60s, mental health providers used psychedelics to help patients open up about difficult memories. Then, the drugs were banned. Now there’s a resurgence. Psychedelics like MDMA, psilocybin, and ketamine are being studied as solutions for anxiety, depression, and PTSD. Findings show that drugs like MDMA are especially useful in the context of healing from trauma. Rachel Yehuda, director of the Center for Psychedelic Psychotherapy and Trauma Research, and Gita Vaid, a psychologist and psychoanalyst who researches ketamine assisted psychotherapy, discuss psychedelic therapies with Alison Snyder of Axios.
“Aspen Ideas to Go” is a weekly show featuring fascinating speakers who have presented at the Aspen Ideas Festival and other public programs offered by the Aspen Institute. For a curated listening experience, subscribe to the podcast on Apple Podcasts or find an archive of episodes here.
As a 501(c)(3) nonprofit organization, the Aspen Institute is nonpartisan and does not endorse, support, or oppose political candidates or parties. Further, the views and opinions of our guests and speakers do not necessarily reflect those of the Aspen Institute.
